Stock STTK SHATTUCK LABS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Shattuck Labs, Inc.

Equities

STTK

US82024L1035

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-05 pm EDT 		5-day change 1st Jan Change
7.39 USD +3.36% Intraday chart for Shattuck Labs, Inc. +2.07% +3.65%
May. 14 Shattuck Labs to Present Additional Data from the Phase 1B Dose Expansion Clinical Trial of Sl-172154 with Azacitidine in Frontline Higher-Risk Myelodysplastic Syndromes (Hr-Mds) and Tp53 Mutant Acute Myeloid Leukemia Patients At the European Hematology Association 2024 Congress CI
May. 02 Shattuck Labs, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
SHATTUCK LABS, INC.
Other Biotechnology & Medical Research
+3.36%+2.07%+3.65%+156.60% - 351M
Bearish
Bullish
Bullish
  1. Stock Market
  2. Equities
  3. STTK Stock
  4. Charts Shattuck Labs, Inc.
  5. Relative Strength Chart